Tag Archive > Diabetes Survey

New NICE Guideline for Type 2 Diabetes Recognises Benefits From Newer Agents for Blood Glucose Control

London (ots/PRNewswire) – – For Healthcare and Pharmaceutical Correspondents Only – NICE Recommends Considering DPP-4 Inhibitors as a Second Line Treatment Option in Appropriate Patients Merck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from the National Institute for Health and Clinical Excellence (NICE) in the [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,